Evidence map›Paper›PMID 41889917›Full record

ArticlebioRxiv : the preprint server for biology2026

Comparison of Four Assays That Measure Antibodies to Ebola Virus Glycoprotein.

Irina Maljkovic Berry, Safaa Ben Farhat, Viviane Callier, Céline Roy, Natasha Dubois Cauwelaert, Edouard Lhomme, Prabha Chandrasekaran, Amie Jarra, Harrison Gichini, Scott Anthony and 21 more

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Irina Maljkovic BerryIntegrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD 21702, USA.ORCID 0000-0001-8555-5352
Safaa Ben FarhatUniversity of Bordeaux, INSERM, Institut Bergonié, CHU de Bordeaux, CIC 1401, Euclid/F-CRIN clinical trials platform, F-33000 Bordeaux, France.ORCID 0009-0005-5198-2790
Viviane CallierClinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.ORCID 0000-0002-9754-560X
Céline RoyUniversity of Bordeaux, INSERM, Institut Bergonié, CHU de Bordeaux, CIC 1401, Euclid/F-CRIN clinical trials platform, F-33000 Bordeaux, France.
Natasha Dubois CauwelaertFrench Institute for Health and Medical Research (INSERM), 75013 Paris, France.
Edouard LhommeUniversity of Bordeaux, INSERM, Institut Bergonié, CHU de Bordeaux, CIC 1401, Euclid/F-CRIN clinical trials platform, F-33000 Bordeaux, France.
Prabha ChandrasekaranIntegrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD 21702, USA.
Amie JarraIntegrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD 21702, USA.
Harrison GichiniIntegrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD 21702, USA.
Scott AnthonyIntegrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD 21702, USA.
Nicolas BernaudFrench Institute for Health and Medical Research (INSERM), 75013 Paris, France.
Christine SchwimmerUniversity of Bordeaux, INSERM, Institut Bergonié, CHU de Bordeaux, CIC 1401, Euclid/F-CRIN clinical trials platform, F-33000 Bordeaux, France.
Martine PeetersRecherche Translationnelle Appliquée au VIH et aux Maladies Infectieuses, University of Montpellier, Institut de Recherche pour le Développement, INSERM, 34090, Montpellier, France.
Guillaume ThaurignacRecherche Translationnelle Appliquée au VIH et aux Maladies Infectieuses, University of Montpellier, Institut de Recherche pour le Développement, INSERM, 34090, Montpellier, France.
Neraide BiaiRecherche Translationnelle Appliquée au VIH et aux Maladies Infectieuses, University of Montpellier, Institut de Recherche pour le Développement, INSERM, 34090, Montpellier, France.
Stephen B KennedyPartnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), Monrovia, 1000 Liberia.
Mark KiehPartnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), Monrovia, 1000 Liberia.
Sarah M BrownePartnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), Monrovia, 1000 Liberia.
Mosoka FallahNational Public Health Institute of Liberia, Monrovia, Liberia.
Patrick MutomboInstitut de Recherche Biomédicale (INRB), Kinshasa - Gombe, DRC.
Emmanuel LokiloInstitut de Recherche Biomédicale (INRB), Kinshasa - Gombe, DRC.
Olivier Tshiani MbayaClinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
Lisa HensleyIntegrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD 21702, USA.
Ian CrozierClinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
Richard T DaveyLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Yves LévyFrench Institute for Health and Medical Research (INSERM), 75013 Paris, France.
Ahidjo AyoubaRecherche Translationnelle Appliquée au VIH et aux Maladies Infectieuses, University of Montpellier, Institut de Recherche pour le Développement, INSERM, 34090, Montpellier, France.
Laura RichertUniversity of Bordeaux, INSERM, Institut Bergonié, CHU de Bordeaux, CIC 1401, Euclid/F-CRIN clinical trials platform, F-33000 Bordeaux, France.
H Clifford LaneLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Cavan ReillyDivision of Biostatistics and Health Data Science, University of Minnesota, Minneapolis, MN, USA.
Dean A FollmannBiostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Funding

WORK ORDER 126643 B539 EXPAND IC SUITE75N91019D00024 · NIAID · LEIDOS BIOMEDICAL RESEARCH, INC. · PI BRISCOE, LYNN · 2019 to 2025
$3932.6M
NIH HHS 75N91019D00024NIH HHS HHSN272201800013C
6 · The paper itself

Abstract

The accurate measurement of Ebola virus (EBOV)-specific antibody responses is crucial to assessing immunity induced by EBOV infection or vaccination. For this purpose, the Filovirus Animal Nonclinical Group (FANG) anti-EBOV glycoprotein (GP

Indexed as

antibodyassay comparisonEbola virusELISAglycoprotein

Identifiers

PMID41889917
PMCPMC13015300

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.